Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Case-control Study Supporting the Use of Liquid Biopsy in the Targeted Therapy for Lung Cancer

Asian Pacific journal of cancer prevention : APJCP - 27 Jul 2018

Dai Li-Jun, Wang Chun, Ding Zhen-Yu

Abstract excerpt

Backgrounds: Targeted therapy for lung cancer depends on the genetic testing. Liquid biopsy provides a valuable source for the genetic testing. However, direct evidence was lacking for whether liquid biopsy could guide the targeted therapy. Methods: In this retrospective study, the admitted patients from Jan 2015 to Feb 2016 were screened through a pre-established database. Patients with metastatic,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Liquid Biopsy

Share to Molecular Targeted Therapy

Share to Protein Kinase Inhibitors

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 30049184
DOI: 10.22034/APJCP.2018.19.7.1761
PMCID: PMC6165644

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Case-control Study Supporting the Use of Liquid Biopsy in the Targeted Therapy for Lung CancerPMID 30049184Read ↗

The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation.Semantic proximity Read ↗

Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.Semantic proximity Read ↗

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era.Semantic proximity Read ↗

Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients.Semantic proximity Read ↗

Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients.Semantic proximity Read ↗

The evolving role of liquid biopsy in lung cancer.Semantic proximity Read ↗

EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia.Semantic proximity Read ↗

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.Semantic proximity Read ↗

Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung Cancer.Semantic proximity Read ↗

Biomarkers and molecular profiling in non-small cell lung cancer: an expanding role and its managed care implications.Semantic proximity Read ↗

Liquid-based cytology specimens for next-generation sequencing in lung adenocarcinoma: challenges and evaluation of targeted therapy.Semantic proximity Read ↗

The Diagnostic Accuracy of Liquid Biopsy in EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of 40 Studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.